Graftskin engineered tissue: ORG began a 200-patient pivotal trial

Organogenesis Inc. (ORG), Canton, Mass. Product: Graftskin engineered tissue Indication: Diabetic ulcers Status: ORG began a 200-patient pivotal trial with Graftskin with funding support from Sandoz....